About
Functional antibodies based on novel and proprietary targets
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibody
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
72
By Phase
PHASE1/PHASE2: 2
By Status
TERMINATED: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
Today
Hover over trial bars to see details
Recent Trials
NCT00504842Lead Sponsor
Transcranial Ultrasound in Clinical SONothrombolysis
PHASE1/PHASE2Terminated
72 participants
Started: Dec 31, 2006 · Completed: Mar 31, 2008
NCT00507806Lead Sponsor
Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke
PHASE1/PHASE2Terminated
Started: Mar 31, 2005 · Completed: May 31, 2006
Locations (1)
Headquarters
Hamburg, Germany
Map
Loading map...